As used herein, the phrase "therapeutically effective pediatric dose of albuterol" means a safe and acceptable amount of albuterol for pediatric patients based ...
... albuterol sulfate) may be used by nebulization. Preferably, the nebulizer flow rate is adjusted to deliver the albuterol sulfate over 5 to 15 minutes.
Said mixture being suitable for nebulization in a nebulizer. In an alternative embodiment, the present invention also comprises a device for use in the relief ...
Albuterol sulfate is a white to off-white crystalline solid. It is soluble in water and slightly soluble in ethanol. PROVENTIL® HFA Inhalation Aerosol is a ...
This property is desirable in crystals to be used in the preparation of an aerosol formulation adapted for use in a metered dose inhaler, because such ...
... albuterol sulfate) may be used by nebulization. Preferably, the nebulizer flow rate is adjusted to deliver the albuterol sulfate over 5 to 15 minutes.
The administration of aerosol formulations of medicaments by means of pressurized, metered-dose inhalers (MDIs) is used widely in therapy, such as in the ...
Preferably, the pharmaceutical composition is an aerosol formulation adapted for administration using a metered dose inhaler, the aerosol formulation comprising ...
An aerosol solution composition for use in an aerosol inhaler comprises an active material, a propellant containing a hydrofluoroalkane, a cosolvent and ...
to evaluate the aerosol characteristics and delivered dose of Albuterol sulfate using the Pneuma™ inhaler device. The study was designed to evaluate device ...
... solution for use in inhalation therapy and method of preparing it ... Multi-use albuterol maintenance therapy formulations and devices therefor. US8834931B2 ...
... use in an oral inhaler for aerosol medicines. NZ504021A * 1997-10-17 ... inhalation solution and application thereof. * Cited by examiner, † Cited by ...
An aerosol solution composition for use in an aerosol inhaler comprises an active material, a propellant containing a hydrofluoroalkane, a cosolvent and ...
... safe flunisolide aerosol formulations for oral inhalation. US6129905A ... use in an oral inhaler for aerosol medicines. NZ504021A * 1997-10-17 2003-04 ...
... Albuterol sulfate suspension aerosol formulations. WO1992022287A1 1991-06-10 ... solution or suspension medium, used after dilution for treatment of asthma by ...
An aerosol solution composition for use in an aerosol inhaler comprises an active material, a propellant containing a hydrofluoroalkane, a cosolvent and ...